INC Research Holdings

INC Research is a leading, global full-service clinical research organization (CRO) providing the full range of Phase I to IV clinical development services for the world's pharmaceutical, biotech and medical device industries. As a therapeutically focused CRO, with a Trusted Process delivery methodology, developing the medicines people need is something we take personally. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, investigative sites and patients to accelerate the delivery of new medicines to market to improve world health. We were ranked "Top CRO to Work With" by sites worldwide in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 100 countries.

Company Growth (employees)
Type
Public
HQ
Raleigh, US
Founded
1998
Size (employees)
6,800 (est)
INC Research Holdings was founded in 1998 and is headquartered in Raleigh, US

INC Research Holdings Office Locations

INC Research Holdings has an office in Raleigh
Raleigh, US (HQ)
600 3201 Beechleaf Ct

INC Research Holdings Data and Metrics

INC Research Holdings Financial Metrics

INC Research Holdings's revenue was reported to be $381.9 m in Q1, 2017
USD

Revenue (Q1, 2017)

381.9 m

Net income (Q1, 2017)

21.2 m

EBIT (Q1, 2017)

34.8 m

Market capitalization (18-Aug-2017)

3.1 b

Cash (31-Mar-2017)

164.4 m
INC Research Holdings's current market capitalization is $3.1 b.
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.2 b1.4 b1.6 b

Revenue growth, %

19%15%

Operating expense total

1.1 b1.2 b1.5 b

EBIT

63.6 m152.4 m155.4 m

EBIT margin, %

5%11%10%

Interest expense

62.2 m60.8 m(53 m)(15.6 m)(12 m)

Interest income

249 k192 k216 k

Pre tax profit

(28.2 m)

Income tax expense

(35.7 m)10.8 m4.7 m(13.9 m)(21.5 m)

Net Income

(23.5 m)117 m112.6 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

308.9 m337.3 m350.1 m413.1 m399.6 m391.8 m381.9 m

General and administrative expense

35.8 m37.1 m40.4 m43.5 m42.6 m41.7 m

Operating expense total

35.8 m37.1 m40.4 m43.5 m42.6 m41.7 m

EBIT

32.4 m35.9 m44.3 m32.5 m39.7 m39.4 m34.8 m

EBIT margin, %

10%11%13%8%10%10%9%

Interest expense

(5.4 m)(4.2 m)(3.1 m)(3 m)(3.1 m)(3.2 m)(3.1 m)

Interest income

84 k45 k28 k34 k43 k62 k112 k

Pre tax profit

30.5 m40.3 m24.4 m33.4 m33.4 m28.3 m

Income tax expense

(5.3 m)(310 k)(2.5 m)(7 m)(2.9 m)(6.1 m)(7.1 m)

Net Income

25.3 m23.3 m37.8 m17.4 m30.4 m27.3 m21.2 m
USDY, 2011Y, 2012Y, 2013FY, 2014FY, 2015FY, 2016

Cash

71 m81.4 m97 m126.5 m85 m102.5 m

Accounts Receivable

6.2 m6.6 m

Inventories

35.4 m38.6 m34.2 m

Current Assets

426.9 m422 m522.6 m

PP&E

43.7 m44.8 m58.3 m

Goodwill

556.9 m553 m552.5 m

Total Assets

1.2 b1.2 b1.3 b

Accounts Payable

16.5 m22.5 m23.7 m

Total Debt

11.9 m

Current Liabilities

379.8 m474.6 m466.7 m

Total Liabilities

987 m

Additional Paid-in Capital

634.9 m559.9 m573.2 m

Retained Earnings

(217.1 m)(301.5 m)(230 m)

Total Equity

392.2 m217.4 m301.5 m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

3.2 x5.6 x4.3 x
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

156.3 m98.5 m136.1 m53.2 m91.9 m102.9 m164.4 m

Current Assets

477.3 m426.7 m521.3 m450.1 m484.4 m487 m539.1 m

PP&E

41.8 m40.5 m39.7 m45.5 m46.4 m46 m57.5 m

Goodwill

553.6 m553.6 m552.8 m553.2 m552.8 m553 m553.1 m

Total Assets

1.3 b1.2 b1.3 b1.2 b1.3 b1.2 b1.3 b

Accounts Payable

14 m14.8 m14.3 m40.4 m27.1 m22.2 m18.9 m

Current Liabilities

398.1 m412.2 m462.2 m472.9 m474.5 m482.7 m458.2 m

Additional Paid-in Capital

635.7 m583.5 m584 m564.2 m572.6 m565.5 m583 m

Retained Earnings

(191.9 m)(266.1 m)(228.2 m)(276.5 m)(246.1 m)(267.5 m)(210.8 m)

Total Equity

409 m280.4 m317.9 m252.1 m288.6 m261.9 m335.4 m

Financial Leverage

3.1 x4.3 x4.1 x4.9 x4.3 x4.8 x3.9 x
USDFY, 2014FY, 2015FY, 2016

Net Income

(23.5 m)117 m112.6 m

Depreciation and Amortization

54.5 m56 m59.2 m

Accounts Receivable

(2.7 m)(5.6 m)(8.9 m)

Inventories

3.4 m1.1 m2.6 m

Accounts Payable

25.7 m8.2 m6.7 m

Cash From Operating Activities

29.5 m(41.4 m)109.3 m

Purchases of PP&E

(25.6 m)(21.1 m)(31.4 m)

Cash From Investing Activities

(27.9 m)(21.1 m)(31.4 m)

Long-term Borrowings

(164.1 m)(475 m)

Dividends Paid

(375 k)

Cash From Financing Activities

(67.7 m)(211.4 m)(53.3 m)

Interest Paid

64.3 m17.5 m11.6 m

Income Taxes Paid

6.3 m8.3 m24.3 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

25.3 m23.3 m37.8 m17.4 m30.4 m27.3 m21.2 m

Depreciation and Amortization

4.8 m13.9 m13.8 m14.4 m14.5 m14.8 m15.6 m

Accounts Payable

14.8 m14.3 m40.4 m27.1 m22.2 m18.9 m
USDY, 2017

Revenue/Employee

56.2 k

Financial Leverage

3.9 x

INC Research Holdings Operating Metrics

FY, 2014FY, 2015FY, 2016

Facilities

737073

    INC Research Holdings Market Value History

    Traffic Overview of INC Research Holdings

    INC Research Holdings Online and Social Media Presence

    INC Research Holdings Company Life and Culture

    You may also be interested in